The information in this section is intended for visitors outside the United States.
The Support PathTM patient assistance program assists eligible hepatitis C patients in the United States access Sovaldi® (sofosbuvir), Epclusa® (sofosbuvir/velpatasvir) or Harvoni® (ledipasvir/sofosbuvir). The program offerings include:
To learn more about Support PathTM, please call 1-855-769-7284, Monday through Friday between 9:00 a.m. and 8:00 p.m. (Eastern Time).